FFA
ASMB icon

Frazier Financial Advisors’s Assembly Biosciences ASMB Stock Holding History

Frazier Financial Advisors’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$10 – 616
2025
Q1 		$10 Hold
1
– – ﹤0.01% 602
2024
Q4 		$17 Hold
1
– – ﹤0.01% 636
2024
Q3 		$16 Hold
1
– – ﹤0.01% 834
2024
Q2 		$14 Buy
+1
New +$14 ﹤0.01% 975

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCM
Monimus Capital Management Woodbridge, New Jersey $361M AUM 21.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Frazier Financial Advisors's ASMB Position: Q2 2025 in Review

Frazier Financial Advisors sold out of Assembly Biosciences (ASMB) in Q2 2025, closing a stake of 1 share — an estimated $10 sold.

Frazier Financial Advisors first reported a position in ASMB in Q2 2024 and held it in 4 quarters. The position peaked at $17 in Q4 2024. 33 funds tracked by Wall St. Rank hold ASMB as of Q2 2025.

  • Frazier Financial Advisors reported no remaining Assembly Biosciences position as of Q2 2025 after selling out during the quarter.
  • Frazier Financial Advisors sold 1 Assembly Biosciences share in Q2 2025, an estimated $10.
  • Frazier Financial Advisors first reported a position in Assembly Biosciences in Q2 2024 and held it in 4 quarters.
  • Frazier Financial Advisors's Assembly Biosciences position peaked at $17 in Q4 2024.
  • 33 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2025.

Based on Frazier Financial Advisors's 13F filing for Q2 2025, filed 28 Jul 2025.